2026 CBP ACE & FDA OASIS Enforcement Update: MoCRA Cosmetic FEI & QMSR Device 510(k) Affirmation of Compliance cross-checks are active at Los Angeles, Newark, Miami & Savannah ports.
Raw CBP/OASIS Entity String: XIAMEN NUTRIGUMMY BIOSCIENCES CO., LTD.
FSVP Lead Auditor Note: Major pectin functional gummy OEM (apple cider vinegar, ashwagandha, sea moss, and sleep gummies) supplying TikTok Shop and Amazon FBA brands. High detention frequency for 21 CFR 101.36 Supplement Facts panel formatting errors and disease claims on private-label jars.
Primary US Port
Los Angeles
Last FDA Inspection
2026-01-14
VAI (Voluntary Action Indicated)
Detained Cargo Value
$153,600
Across 3 holds
Est. US Containers/Yr
~280 TEUs
CBP ACE Bill of Lading
Composite Procurement RiskCRITICAL_IMPORT_ALERT
76/ 100 Risk Score
5-Year Import Refusals:3
Active Warning Letters:1
FDA Enforcement Recalls:0
Red List — Import Alert 54-16 & 99-20 (Supplement Facts & Claims)
CFSAN Office of Dietary Supplement Programs (ODSP)
Dietary Supplement CGMP (21 CFR Part 111) & Misbranding Violations
Failed to conduct at least one identity test on incoming botanical ashwagandha root extract before compounding, and declared dietary ingredients inside the 2% Daily Value box in incorrect order.
Misbranded: Fails to bear required Nutrition Facts or Supplement Facts panel format
The product label uses foreign nutrition tables (e.g., EU/CN per-100g format) instead of mandatory US FDA per-serving Nutrition/Supplement Facts formatting.
Importer Remediation Checklist:
Submit Form FDA 766 proposing custom sticker relabeling under bond before customs liquidation.
Update dielines to 21 CFR 101.9 (Nutrition Facts) font size and declaration standards.
Unapproved New Drug: Cosmetic or Supplement making therapeutic disease claims
The product (often a skincare serum, device, or dietary supplement) uses medical or disease-cure claims on its packaging or website without an approved NDA/ANDA.
Importer Remediation Checklist:
Audit all product box copy, package inserts, and linked Shopify/Amazon URLs for therapeutic verbs ('cures', 'treats inflammation', 'heals acne').
File an FDA Relabeling Application (Form FDA 766) if the violation is purely on physical packaging.
Verify active ingredients against OTC Monograph compliance requirements.
Adulterated: Bears or contains an unsafe or uncertified color additive
The cosmetic or food item contains a dye/pigment either banned in the US or lacking an FDA batch certification number (e.g., FD&C Red No. 40 without batch cert).
Importer Remediation Checklist:
Request FDA Color Additive Lot Certification numbers from the raw pigment supplier.
Cross-check eye-area cosmetics against 21 CFR Part 73/74 restricted color lists.
Get an automated Slack/Webhook JSON payload and email alert within 15 minutes whenever FDA OASIS logs a new detention, Import Alert Red List addition, or Warning Letter for Xiamen NutriGummy Biosciences Co., Ltd. before you wire your 70% balance payment.
TIER 3 • URGENT US FDA COMPLIANCE COUNSEL DISPATCH (CPL VERIFIED)
Respond-By Deadline Priority Triage
Shipment Detained by FDA or Placed on Import Alert? Request Free 24h Detention Evaluation from Licensed US FDA Compliance Counsel
When FDA issues a Notice of FDA Action (Detention), importers typically have only 10 to 20 business days to file a Form FDA 766 relabeling application, submit an accredited private laboratory packet (PLAP), or petition for Import Alert Red List removal before CBP orders refusal and liquidated damages.
Compare Alternative Suppliers in Dietary Supplements, Nutraceuticals & Botanicals
Is Xiamen NutriGummy Biosciences Co., Ltd. (FEI 3017610293) on an FDA Import Alert Red List?
Xiamen NutriGummy Biosciences Co., Ltd. currently carries a Composite FDA Risk Score of 76/100 (CRITICAL_IMPORT_ALERT) in DWPERadar records with status: Red List — Import Alert 54-16 & 99-20 (Supplement Facts & Claims). Primary US port of entry is Los Angeles. Historical records are informational only and should be cross-checked on official FDA dashboards before CBP filing.
What are the main FDA Charge Codes cited against Xiamen NutriGummy Biosciences Co., Ltd.?
Across the 5-year OASIS refusal dataset, Xiamen NutriGummy Biosciences Co., Ltd. has been cited for NUTRITIONAL_LABELING, UNAPPROVED_NEW_DRUG, UNSAFE_COLOR. Importers should review the statutory remediation checklists and Form FDA 766 eligibility before filing CBP entry.